Navigation Links
McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world
Date:1/24/2011

This release is available in French.

McGill University and McGill University scientist Dr. Timothy Geary received a $1-million grant today for landmark research into addressing parasitic diseases through medicines derived from African biodiversity. Grand Challenges Canada, Canada's International Development Research Centre, The Canadian Institutes of Health Research and the Bill & Melinda Gates Foundation have joined together to support this important research which provides a significant Canadian contribution to a serious global health issue.

More than 1 billion people, or one-sixth of the world's population, suffer from Neglected Tropical Diseases (NTDs), which cause disfigurement, disability and even death in the developing world. Dr. Geary's research focuses on parasitic worms, or helminths, which live inside the body. Diseases such as hookworm, river blindness and elephantiasis cause stunted growth and cognitive impairment in children, horrific debilitating and disfiguring symptoms in adults, and make escaping the cycle of poverty virtually impossible.

"While there have been advances in the past few years in providing drugs to control the disease, there is so much more that can be done to eliminate NTDs and bring hope to many for a better future," said Dr. Geary, Director of the Institute of Parasitology at McGill. "The drugs we plan to develop through this research will combat growing resistance to existing therapies, an important next step in the treatment and control of parasitic disease."

Dr. Geary's breakthrough research, conducted in partnership with Dr. Eliane Ubalijoro of the Institute for the Study of International Development at McGill, focuses on identifying compounds from African botanical and microbial sources that can lead to new drugs to eliminate parasitic worms from the body. In this approach, he works in partnership with African scientists, particularly Dr. Kelly Chibale of the University of Cape Town, and Drs. Berhanu Abegaz and Kerstin Marobela of the University of Botswana, believing that partners from disease-endemic countries are critically important for finding new solutions to these infections. This team will conduct research both at McGill and in Africa.

"This is about Canadians helping Africans help themselves; an effective and long-term approach to the challenges developing countries face," said Dr. Peter A Singer, CEO of Grand Challenges Canada. "This is a milestone celebration for Grand Challenges Canada. We are less than a year old and I am proud to say this is our first grant announcement. For us, this is like fireworks lighting up the sky on Canada Day."

"We're delighted that this first grant from Grand Challenges Canada supports a partnership between researchers in Canada and researchers in Africa, one devoted to drawing on both Canadian and African ingenuity to solve a persistent and debilitating health problem in Africa" said David Malone, President of Canada's International Development Research Centre. "

The $1-million award is collaboration among three funders: $500,000 from the Bill & Melinda Gates Foundation; $250,000 from Grand Challenges Canada through the Canadian government's Capital Development Innovation Fund; and $250,000 from the Canadian Institutes of Health Research (CIHR).

"We believe in the quality of Dr. Geary's research and the potential for a significant Canadian contribution to addressing these debilitating diseases which plague so many in the developing world," said Dr. Pierre Chartrand, Vice-President Research, Canadian Institutes of Health Research. "We have to do more than just share information across traditional political and national lines: we have to invest in the development of local response and research capacity."

Over the past five years, the world has made tremendous progress in addressing some of the greatest global health issues," said Dr. Steven Buchsbaum, Deputy Director of Discovery, Bill & Melinda Gates Foundation. "Partnerships are increasingly critical and we look forward to working with Grand Challenges Canada as we engage the best minds to harness advances in science and technology and save lives. We hope Canada's important commitment inspires others to take action.""

"We are most appreciative of this funding and the opportunity it creates for Drs. Geary and Ubalijoro and McGill to make a significant Canadian contribution to addressing these serious global health challenges," said Dr. Rose Goldstein, Vice-Principal (Research and International Relations) at McGill. "All Canadians should be proud of the contribution this county is making on the international stage to address these sometimes fatal ailments diseases and conditions which those of us who live in the developed world often forget are very real and terrifying risks for large numbers of people."


'/>"/>

Contact: Vronique Perron
veronique.perron@cihr-irsc.gc.ca
613-952-5746
Canadian Institutes of Health Research
Source:Eurekalert

Related medicine news :

1. Coordinator of UN high-level task force to open McGill Food Security Conference
2. McGill to host inter-university Family Medicine Student Symposium
3. Water management and malnutrition crucial issues at McGill food conference
4. McGill pair capture NSERC prizes
5. McGills Orphan Drug research offers hope
6. McGill-UBC project creates mouse grimace scale to help identify pain in humans and animals
7. MUHC/McGill Ocular Pathology Laboratory celebrates a decade of progress
8. $300,000 CIHR grant awarded to Medicago, the Research Institute of the MUHC and McGill University
9. Patent awarded for method to dampen immune response
10. Dana Farber/Harvard Cancer Center awarded $11.7M grant to support prostate cancer research
11. Boston University School of Medicine awarded grants to improve early detection of lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... According to recent statistics, there are nearly ... physical therapy clinics. Each physical therapy professional and every clinic has a duty ... time, staying afloat in a competitive industry is also essential. The solution that many ...
(Date:5/31/2016)... Santa Barbara, CA (PRWEB) , ... May 31, 2016 , ... Throughout the day, adults ... soda for sustained motivation and awareness, but what they could be reaching for instead is ... green tea plants that are grown in Japan. This sacred tea is harvested from early ...
(Date:5/31/2016)... ... ... years ago it was revolutionary: enabling the people who hear distressing voices to speak ... approach has proven transformative, both for people who hear voices and for the field ... around the world, but it still lags in the United States. , Now, Gail ...
(Date:5/31/2016)... ... 31, 2016 , ... Spartan Bioscience today introduced the Spartan ... convenience. , The Cube is exceptionally small—it takes up the space of a ... into any space, whether in a hospital, doctor’s office, or pharmacy. , The ...
(Date:5/31/2016)... Francisco, CA (PRWEB) , ... May 31, 2016 , ... ... cases for digital-minded professionals, announces the waxed-canvas and leather Duo Dopp Kit , ... durable waxed canvas or ballistic nylon, the Duo is smartly designed for ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... HILDEN , Germany and ... QIAGEN N.V. (NASDAQ: ... an extensive package consisting of a quality control set ... NGS System, reinforcing the proven accuracy of its next-generation ... and training for laboratories. QIAGEN has incorporated the Horizon ...
(Date:5/31/2016)... , May 31, 2016 ... market is progressing at a CAGR of 10.6% within ... was valued at US$0.46 bn in 2013. Owing to ... expected to reach US$0.88 bn by the end of ... derived from the market,s holistic representation in a research ...
(Date:5/31/2016)... ZIONA, Israel , May 31, 2016 ... company utilizing its proprietary plant-based rhCollagen technology for tissue ... from the Chief Scientist of Israel,s ... its NIS 12 million development project for 2016. The Chief ... than last year,s authorized grant, which totaled NIS 4.7 ...
Breaking Medicine Technology: